GLP-1 Weight Loss Drugs and Their Impact on Value-Based Care Webinar Recording

  • Sale
  • Regular price $197.00


Watch On-demand as a panel of distinguished experts discusses the potential future role of GLP-1 weight loss drugs in delivering value-based care.
Faculty includes Angela Fitch, M.D., Julie Balter and Emma Hoo. (Please see full bios below)

  • On-Demand Webinar Video and Presentation PDF: $197

    Overview

    A group of drugs known as glucagon-like peptides 1 (GLP-1) were originally developed to better manage diabetes. But GLP-1 drugs such as Ozempic, Mounjaro and Wegovy have more recently been used to combat obesity, with some users reporting weight loss of 60 pounds or more that remains permanent so long as they continue taking the medication. A new study released by the manufacturer of Wegovy also concluded that using the drug for weight loss reduces the risk of serious cardiovascular episodes by about 20%. Manufacturers are also formulating new GLP-1s that may be even more effective in achieving dramatic and permanent weight loss.

    That begs the question: Will these drugs play a role in value-based care for patients with chronic conditions such as obesity, or will the cost of GLP-1s take such a proposition off the table?

    Learning Objectives

    • What are GLP-1 drugs and how do they work?
    • The GLP-1 price/cost curve
    • The impact of GLP-1 on the health of patients/users
    • Who is being prescribed GLP-1 drugs?
    • How GLP-1s have been contributing to overall healthcare costs in the U.S.
    • Will GLP-1 drugs impact the volumes of bariatric surgery?
    • Employer, payer and provider opinions and responses to the use of GLP-1s for weight control
    • What the future holds for GLP-1 drugs and value-based cared

      Potential Audience

      • Physicians
      • Hospital Executives
      • Healthcare System Executives
      • Health Plan Executives
      • Healthcare Marketing Executives
      • Patient and Consumer Advocates

        Faculty

        Angela Fitch, M.D
        President, Obesity Medicine Association, Co-Founder, Chief Medical Officer, knownwell

        Angela Fitch, M.D

        Angela Fitch, M.D., is a leader in the field of obesity medicine. She is the current president of the Obesity Medicine Association. She served as chair of the clinical management section of the Obesity Society in 2015–2016.

         

        She practiced primary care for 10 years before becoming a diplomate of the American Board of Obesity Medicine in 2012. Aside from co-founding knownwell, Dr. Fitch is an assistant professor of medicine at Harvard University and the former co-director of the Massachusetts General Hospital Weight Center. She is board-certified in obesity medicine, internal medicine, and pediatrics.

         

        Julie Balter
        Senior Manager, Clinical Policy, Alliance of Community Health Plans (ACHP)

        Photo Julie Balter

        Julie helps shape and execute the Alliance of Community Health Plan’s clinical innovation strategy, which supports and advances ACHP’s vision and mission and guides its learning and innovation efforts. In this role she supports ACHP’s pharmacy director community, research portfolio, and clinical programming.

        Prior to joining ACHP, she worked for the National Association of Community Health Centers, where she served as the specialist of provider networks, supporting state-level accountable care efforts. She holds a law degree from American University and an undergraduate degree from George Washington University.


        Emma Hoo
        Director, Value-Based Purchasing, Purchaser Business Group on Health (PBGH)

        Photo Emma Hoo

        Emma Hoo directs initiatives to implement high-value measures, including patient-reported outcomes measures, and directs works to advance mental health care accountability, outcomes and measurement. Emma works with PBGH members and other purchasers to improve the transparency and value delivered to employees and employers from plan, provider and other partnerships.

        Prior to joining PBGH in 1997, Emma was director of operations for a Northern California medical group, with responsibility for contracting, data analysis and information systems.

        Emma received her Bachelor of Arts in social studies from Harvard University.

         

        Registration Details

        Register above or you can also register by phone: 209.577.4888. For Corporate Site licensing information please email adamg@mcol.com. We look forward to your attendance!

        MCOL Premium members receive a 50% discount on all Healthcare Web Summit events. Members can get the discount code by logging onto the Premium Member Website and then going to the Premium Member HealthWebsummit page. Non-members can learn about MCOL Premium memberships and sign-up to get the 50% discount on this and future events.

        Need a Printable Form? Download a registration form you can fax or mail.

        Cure for the Common Webinar

        In addition to the main presentation, this webinar will include a moderated audience Q&A. Within one business day of your registration, you'll receive login information. You will receive a reminder email 1 day and 1 hour before the live event.

        One day after the live webinar, you'll receive a follow-up email which will include a link to the presentation slides. You’re also welcome to provide feedback via this email as well as submit additional questions to be forwarded to the speakers. For support before, during or after the event, please contact HealthcareWebSummit office at 209.577.4888.